Pharmaxis Ltd's (ASX:PXS) (FRA:UUD) Gary Phillips speaks to Proactive's Andrew Scott soon after announcing they've entered a world-first clinical trial aiming to stop scars forming after trauma - particularly following burn injuries. Distinguished surgeon and burns expert Professor Fiona Wood AM is leading a group of researchers from the University of Western Australia (UWA) and Fiona Stanley Hospital to test the treatment in the first human trials.
Pharmaxis details world-first clinical trial of treatment to prevent wound and burn scars
